ORGO
Organogenesis Holdings Inc.Healthcare · $177M market cap
Verdict
Share price
$1.33
close of Oct 3, 2026
Fair value
$2.98
Sticker Price
Payback Price
$1.19
buy price
ORGO is Undervalued: at $1.33 it trades 55% below its fair value of $2.98. Its buy price (Payback Price) is $1.19, 11% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow ORGO
Get notified when it reaches its buy price of $1.19. Free.
Create a free accountAbout Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital…
Drug Manufacturers - Specialty & Generic
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works